Our team’s previous research (Zhao et al., 2023) had shown that antagonizing DR5 significantly enhanced survival rates in an acute radiation sickness mouse model, reduced tissue damage as well as inflammatory responses, and inhibited the excessive apoptosis of functional cells. This evidence concerns the gene TNFRSF10B and radiation injury.